Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera… - Clinical and Vaccine …, 2009 - Am Soc Microbiol
Listeria monocytogenes has been exploited previously as a vaccine vector for the delivery of
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
A Wallecha, PC Maciag, S Rivera… - Clinical and Vaccine …, 2008 - europepmc.org
Listeria monocytogenes has been exploited previously as a vaccine vector for the delivery of
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
[PDF][PDF] Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera, Y Paterson… - CLINICAL AND …, 2009 - Citeseer
(FACS) reagents. Peptides were synthesized by EZBiolabs (Westfield, IN), and
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy
A Wallecha, PC Maciag, S Rivera… - Clinical and …, 2009 - pubmed.ncbi.nlm.nih.gov
Listeria monocytogenes has been exploited previously as a vaccine vector for the delivery of
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
[PDF][PDF] Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera… - CLINICAL AND …, 2009 - researchgate.net
(FACS) reagents. Peptides were synthesized by EZBiolabs (Westfield, IN), and
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
[HTML][HTML] Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera… - Clinical and Vaccine …, 2009 - ncbi.nlm.nih.gov
Listeria monocytogenes has been exploited previously as a vaccine vector for the delivery of
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
[PDF][PDF] Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera… - CLINICAL AND …, 2009 - academia.edu
(FACS) reagents. Peptides were synthesized by EZBiolabs (Westfield, IN), and
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
[PDF][PDF] Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera… - CLINICAL AND …, 2009 - content.stockpr.com
(FACS) reagents. Peptides were synthesized by EZBiolabs (Westfield, IN), and
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy.
A Wallecha, PC Maciag, S Rivera… - Clinical and Vaccine …, 2008 - europepmc.org
Listeria monocytogenes has been exploited previously as a vaccine vector for the delivery of
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
heterologous proteins such as tumor-specific antigens for active cancer immunotherapy …
[PDF][PDF] Construction and Characterization of an Attenuated Listeria monocytogenes Strain for Clinical Use in Cancer Immunotherapy
A Wallecha, PC Maciag, S Rivera… - CLINICAL AND …, 2009 - researchgate.net
(FACS) reagents. Peptides were synthesized by EZBiolabs (Westfield, IN), and
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …
oligonucleotides were synthesized by Invitrogen (Carlsbad, CA). The reagents for ffow …